66 related articles for article (PubMed ID: 9201292)
1. Comparative study of blood insulin levels in breast and endometrial cancer patients.
Gamayunova VB; Bobrov YuF ; Tsyrlina EV; Evtushenko TP; Berstein LM
Neoplasma; 1997; 44(2):123-6. PubMed ID: 9201292
[TBL] [Abstract][Full Text] [Related]
2. [Blood insulin and insulin sensitivity in breast cancer patients of various ages: the effect of smoking].
Tsyrlina EV; Gamaiunova VB; Kovalenko IG; Berstein LM
Vopr Onkol; 1998; 44(1):43-8. PubMed ID: 9578730
[TBL] [Abstract][Full Text] [Related]
3. [The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide].
Bershtein LM; Gamaiunova VB; Kvachevskaia IuO; Tsyrlina EV; Kovalenko IG
Vopr Onkol; 2000; 46(2):191-5. PubMed ID: 10853419
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
5. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
9. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
[TBL] [Abstract][Full Text] [Related]
11. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
[TBL] [Abstract][Full Text] [Related]
12. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
Rajamand N; Ungerstedt U; Brismar K
Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
[TBL] [Abstract][Full Text] [Related]
14. Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.
Potau N; Williams R; Ong K; Sánchez-Ufarte C; de Zegher F; Ibáñez L; Dunger D
Clin Endocrinol (Oxf); 2003 Dec; 59(6):756-62. PubMed ID: 14974918
[TBL] [Abstract][Full Text] [Related]
15. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
Faria AN; Ribeiro Filho FF; Gouveia Ferreira SR; Zanella MT
Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
[TBL] [Abstract][Full Text] [Related]
16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
17. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
Cucinelli F; Soranna L; Perri C; Barini A; Cento RM; Mancuso S; Lanzone A
Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women.
Bastard JP; Vandernotte JM; Faraj M; Karelis AD; Messier L; Malita FM; Garrel D; Prud'homme D; Rabasa-Lhoret R
Diabetes Metab; 2007 Sep; 33(4):261-8. PubMed ID: 17499540
[TBL] [Abstract][Full Text] [Related]
19. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
[TBL] [Abstract][Full Text] [Related]
20. Effect of parathyroid hormone and insulin on extracellular cyclic adenosine-3',5'-monophosphate in patients with benign and malignant breast tumors.
Berstein LM; Semiglazov VF; Vishnevski AS; Dilman VM
Neoplasma; 1978; 25(3):329-35. PubMed ID: 210408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
